The perinatal results achfeved through compensating maternal diabetes by administering the M.T.D. of insulin are positive. They have already been reported [l, 5, 6, 7, 8, 10] and consist of: 1) a reduction in perinatal mortality (P.M.) to values (total P M. 2.9%, corrected P M. 1.9%) of the general P.M. (in 1975 total PM. of the general population in the Clinic 2.5%); 2) near disappearance of foetal macrosomia (3.3% above 4000 g) and normalization of birth weight(newbornweight does not differ from normal newbom weight) [9]; 3) a normal incidence of pathological Symptoms in newborn infants which were not however severe (respiratoiy distress syndrome 0.6%, hypoglycemia 13.4%); 4) reduction of caesarian sections to 24.6%; 5) delivery time did not have to be systematically brought forward, but only in cases where poor conditions of the foetus were apparent (labour induced in 9.6% of cases): 74.7% of the cases gave birth after the 38th week of gestation. The M.T.D. of insulin is the highest quantity of insulin that can be administered without bringing about hypoglycemia. M.T.D. is easily established in a few days by increasing insulin dosage every day with a "small quantity" of fast-acting insulin and then subtracting the last, "small quantity" after the appearance of the first signs of insulin intolerance [4, 5, 6, 7, 8, 10] . The maternal diabetes results compensated to a degree that can be defined "äs strict äs possible". According to this method of treatment, maternal glycemia was not used in our case study äs a guideline to insulin therapy. However, starting in 1971, the 24 hour blood sugar level was routinely checked in order to quantify the above qualitative definition of the degree of compensation. Preliminary data showed that maternal blood glucose levels out into a normal ränge when the insulin M.T.D. has been reached [10] . This paper provides a more detailed study of this aspect.
l Introduction
The perinatal results achfeved through compensating maternal diabetes by administering the M.T.D. of insulin are positive. They have already been reported [l, 5, 6, 7, 8, 10] and consist of: 1) a reduction in perinatal mortality (P.M.) to values (total P M. 2.9%, corrected P M. 1.9%) of the general P.M. (in 1975 total PM. of the general population in the Clinic 2.5%); 2) near disappearance of foetal macrosomia (3.3% above 4000 g) and normalization of birth weight(newbornweight does not differ from normal newbom weight) [9] ; 3) a normal incidence of pathological Symptoms in newborn infants which were not however severe (respiratoiy distress syndrome 0.6%, hypoglycemia 13.4%); 4) reduction of caesarian sections to 24.6%; 5) delivery time did not have to be systematically brought forward, but only in cases where poor conditions of the foetus were apparent (labour induced in 9.6% of cases): 74.7% of the cases gave birth after the 38th week of gestation. The M.T.D. of insulin is the highest quantity of insulin that can be administered without bringing about hypoglycemia. M.T.D. is easily established in a few days by increasing insulin dosage every day with a "small quantity" of fast-acting insulin and then subtracting the last, "small quantity" after the appearance of the first signs of insulin intolerance [4, 5, 6, 7, 8, 10] . The maternal diabetes results compensated to a degree that can be defined "äs strict äs possible". According to this method of treatment, maternal glycemia was not used in our case study äs a guideline to insulin therapy. However, starting in 1971, the 24 hour blood sugar level was routinely checked in order to quantify the above qualitative definition of the degree of compensation. Preliminary data showed that maternal blood glucose levels out into a normal ränge when the insulin M.T.D. has been reached [10] . This paper provides a more detailed study of this aspect.
Materials and methods
Starting in 1971 hospitalized pregnant diabetics underwent a 24-hour glycemia check on a fixed day (Wednesday) of every week. It consisted of 6 samples of capillary blood collected every 4 hours, i.e. at 8 a.m., 12 a.m., 4 p.m., 8 p.m., 12 p.m. and 4 a.m. The patients had fasted from midnight until the 8 a.m. meal. Meals, äs usual, were served at 8 a.m., 12 a.m., 4 p.m. and 6.30p. m. The 12 a.m. and 6.30 p.m. meals were the two main meals of the day. In view of the time relationship between meals and blood sampling (Fig. 1) , 5 out of the 6 samples represent the lower blood glucose levels over the 24 hours (the three samples at 8 a.m., 12 a.m. and 4 p.m. were taken 4 hours after the last meal and immediately before the following one; the two samples at 12 p.m. and 4 a.m. were collected respectively 5*/2 hours and 9*/2 hours after the last meal and 8 hours and 4 hours before the following one), while l sample, at 8 p.m., represents the blood glucose level l x /2 hours after the meal. Calory intake differed from patient to patient. According to our criteria [5, 6, 7, 8, 9 , 10] each < patient had been invited to choose her first menu without any restriction ön quality or quantity. Retrospective analysis showed that the calory content averaged 1900 cal/24 hours and composition, protein glucose and lipids, were respectively 15.5%, 53.2%, 31.3%, with fluctuatiqns of ± 10% in most cases [8] . The M.T.D. of insulin was administered to patients with both clinical and latent diabetes,asestablished in every case by means of a simple method [4, 5, 6, 7, 8, 10] . Blood glucose was measured in an autoanalyzer in the hospital laboratory using the oxidase method. Between 1971, when the 24-hour glycemia check became a routine test, and 1975,388 pregnant diabetics (96.5% of cases treated in the same period), 251 with latent and 137 with clinical diabetes, were checked. The number of tests differed from patient to patient, because they were perförmed weekly and because the duration of the first period of hospitalization (needed to establish the M.T .D. of insulin) and the number and the length of subsequent hospitalization periods (needed to maintain the M.T.D. of insulin in the course of pregnancy) differed. The current report presents data concerning two glycemia checks made during the first hospitalization. The first was perförmed before starting our treatment (patients with latent or chemicäl diabetes who had not yet been treated with insulin, and patients with clinical diabetes that was being conventionally compensated), the second after having established the M.T.D. of insulin, i.e., before the patients were discharged from hospital. For various reasons one or other of these two tests were not perförmed in a few cases, while the set of samples was incomplete in other cases. 161 patients (41% of the cases tested) with the complete set of samples in both tests were included in the study. The patients were divided into groups. 
Results
Before applying our treatment, the average blood glucose values at fasting (Tab. I, Fig. 2 ) and over the 24-hour period (Tab. II, Fig. 3 ) in each group of pregnant diabetics were higher than the corresponding mean values in the control group. Differences vis-a-vis the control group increased, from patients with latent diabetes to those with clinical diabetes and, among the latter, from those with no vascular complications to those with these complications. All differences were statistically significant (p < 0.001). ig. 5. 24 houis blood sugar (mg%) mean and 95% confidence interval for the sample.
Discussion
It is generally agreed that the better the control of diabetes in pregnant diabetics the better the chance of a favourable outcome of pregnancy. Numerous investigations have therefore been carried out to answer the question: what is optimum control of diabetes in pregnancy? It seemed reasonable to look for the answer to this question by attempting to answer another, namely what is the optimum blood glucose value?On this point no agreement has yet been reached. The blood glucose value which pregnant diabetics require to maintain metabolic compensation differs from author to author. In any case, the choice of a predetermined blood glucose value äs the ahn of insulin treatment is more a practical than an ideal sohition.
N Blood glucose represents the index of only one metabolic compartment among those influenced by insulin. The normal value of blood glucose is an individual and not a general characteristic, which can vary considerably and change from day to dayd epending on many factors such äs physical activity, diet. etc. Moreover, the fear of hypoglycemic coma leads one to select a predetermined blood glucose value which is risk-free but far from what is generally considered a normal blood glucose value. On the contrary, minor disturbances in maternal metabolism, äs occur with latent diabete s, are of great consequence to the development of the foetus. Pregnant diabetics in the same metabolic and clinical conditions show varying blood glucose reductions brought ab out by the same quantity of insulin and viceversa. In other words, the reduction in hyperglycemia is not to some extent a dose-related phenomenon. Hence the relative frequence of hypoglycemic coma in case studies of pregnant diabetics while at the same time it is difficult, and often impossible, in practice to achieve predetermined blood glucose values. In the literature these cases have been retrospectively defined äs "non-compensated". This disadventages of using blood glucose äs a guideline in the treatmenj: of pregnant diabetics are overcome by our method of insulin administration. In fact, M.T.D. of insulin is not established on the basis of maternal blood glucose but on the basis of clinical signs [4, 5, 6, 7, 8, 10] . M.T.D. is easily established in a short time in all cases and therefore is guaranteed "a priori" (in our case study no cases were judged "a posteriori" äs poorly compensated, i.e., cases in whichM.TJX was not reached). Hypoglycemic coma is largely prevented by the particular method of insulin administration, which entails a step-by-step increase in insulin dosage (only 6 cases of coma occurred in 479 pregnant diabetics). The results of this study show that blood glucose progressively falls äs insulin increases and levels out at the M.T.D. to unforeseeable and non-predetermined values, which differ from case to case, äs in a normal population, and whose mean values correspond to the mean values of a normal population. Normalization of blood glucose is ensured irrespective of the degree of diabetes and that of hyperglycemia. These positive results complement the positive clinical results of our case study [l, 5,6,7, 8,10] which were summarized at the beginning of this paper. Since our pregnant diabetics underwent their maximal tolerated dose of insulin, it is not easy to foresee any, further improvement in the outcome of pregnancy through a further improvement in insulin treatment. At the same time, each day's results confirm our confidence in the method we have used to treat pregnant diabetics since 1963.
Summary
Between 1970 and 1975 a 24-hour blood glucose check on hospitalized pregnant diabetics (including controls at fasting and five samples of capülary blood at 4-hour intervals) was routinely performed on a given day of every week. Time intervals of blood collections after meals were 4 hours or more in five samples and P/2 hours in one sample (8 p.m.).
Insulin was administered to the maximum tolerated dose (M.T.D.) both to pregnant women with latent and to those with clinical diabetes [4, 5, 6, 7, 8, 10] . The blood glucose data of cases coverning the complete sei of samples both before starting treatment (no insulin therapy given to patients with latent or chemical diabetes and therapy according to traditional criteria given to patients with clinical diabetes) and after reaching the M.T.D. of insulin (161 cases) were compared with data from 24-hour blood glucose checks on 69 non-diabetic pregnant women (control group). Before starting the treatment the average blood glucose values at fasting and over the 24-hour period were higher in each group of pregnant diabetics (latent diabetes: 95 cases; clinical diabetes: 66 cases; without vascular complications: 36 cases; with vascular complications: 30 cases) than in the control group. Differences vis-a-vis the control group were greater in Keywords: Blood sugar, insulin, pregnancy and diabetes.
patients with clinical than in those with latent diabetes, and in patients with vascular complications than in those without. All differences were statistically significant (Tabs. I, II; Figs. 2, 3) . Individual blood glucose values in patients with clinical diabetes were widely distributed around their mean values (Figs. 4, 5) . At the M.T.D. of insulin, the mean values of diabetics and control groups were almost the same. There was no statistical difference between pregnant diabetics (except in patients with latent diabetes) and the control group ( Tabs. I, II; Figs. 2, 3) . Individual blood glucose values were distributed in a narrow ränge (Figs. 4, 5) . The normalization of blood glucose was not the original purpose of our treatment, but the treatment did result in normalization. This positive result is in agreement with the positive perinatal outcome of the cases studied [l, 5, 6, 7, 8, 10] . These results confirm our confldence in the particular method of insulin therapy that we use. (Figures 4, 5) . A la M.T.D. d'insuline les valeurs moyennes des diabetiques et du groupe temoin etaient semblablement les meines. L'on ne notait pas de difference significative entre les diabetiques gravides (les patientes au diabete latent mises a part) et le groupe temoin (Tableaux I et II; Figures 2 et 3) . Les glycemies individuelles se distribuaient dans des limites etroites (figures 4,5). La normalisation des glycemies n'etait pas le propos initial de notre traitement, mais cecui-ci resultait de la normalisation. Ce resultat positif se trouve en accord avec Fevolution perinatale positive des cas etudies [1, 5, 6, 7, 8, 10] . Ces resultats nous confirment dans notre confiance en la methode particuliere de therapeutique insulinique que nous avons utilisee. % Mots-cles: Diabete et grossesse, glycemie, insuline.
